Innate immunity to cytomegalovirus: The Cmv1 locus and its role in natural killer cell function

Microbes and Infection

Volumn 4, Issue 15, 2002, Pages 1491-1503

  Lee, Seung Hwan ^a   Webb, John R ^a   Vidal, Silvia M ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Innate immunity; Murine cytomegalovirus; Natural killer cell; Positional cloning

Indexed keywords

LECTIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN CMV1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALLELE; CELL FUNCTION; CYTOLYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; GENE CLUSTER; GENE IDENTIFICATION; GENE LOCUS; GENETIC HETEROGENEITY; HAPLOTYPE; HOST RESISTANCE; INFECTION RESISTANCE; MOLECULAR CLONING; MOLECULAR GENETICS; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; VIRUS IMMUNITY; VIRUS RESISTANCE;

ANIMALS; ANTIGENS, LY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, NATURAL; IMMUNOGENETICS; KILLER CELLS, NATURAL; LECTINS, C-TYPE;

ANIMALIA; CYTOMEGALOVIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0036932285     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00032-1     Document Type: Review

References (99)

1. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20:2002;197-216.
2. Blackwell J.M. Genetics and genomics in infectious disease susceptibility. Trends Mol. M. 7:2001;521-526.
3. Cooke G.S., Hill A.V. Genetics of susceptibility to human infectious disease. Nature Rev. Genet. 2:2001;967-977.
4. Clegg J.B., Weatherall D.J. Thalassemia and malaria: new insights into an old problem. Proc. Assoc. Am. Physicians. 111:1999;278-282.
5. Ruwende C., Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J. Mol. M. 76:1998;581-588.
6. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:1999;657-700.
7. Qureshi S.T., Skamene E., Malo D. Comparative genomics and host resistance against infectious diseases. Emerg. Infect. Dis. 5:1999;36-47.
8. Best S., Le Tissier P., Towers G., Stoye J.P. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature. 382:1996;826-829.
9. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3 H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
10. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., Gros P., Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. M. 189:1999;615-625.
11. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376.
12. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:1999;189-220.
13. Britt W., Alford C.A. Fields B.N. Fields Virology. 1996;2493-2523 Lippincott-Raven, New York.
14. Rawlinson W.D. Broadsheet. Number 50: Diagnosis of human cytomegalovirus infection and disease. Pathology. 31:1999;109-115.
15. Trincado D.E., Scott G.M., White P.A., Hunt C., Rasmussen L., Rawlinson W.D. Human cytomegalovirus strains associated with congenital and perinatal infections. J. Med. Virol. 61:2000;481-487.
16. Kaufman D.B., Leventhal J.R., Gallon L.G., Parker M.A., Koffron A.J., Fryer J.P., Abecassis M.M., Stuart F.P. Risk factors and impact of cytomegalovirus disease in simultaneous pancreas-kidney transplantation. Transplantation. 72:2001;1940-1945.
17. Levi M. CMV endothelitis as a factor in the pathogenesis of atherosclerosis. Cardiovasc. Res. 50:2001;432-433.
18. Hengel H., Brune W., Koszinowski U.H. Immune evasion by cytomegalovirus - survival strategies of a highly adapted opportunist. Trends Microbiol. 6:1998;190-197.
19. Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nature Rev. Immunol. 1:2001;41-49.
20. Biron C.A., Byron K.S., Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. M. 320:1989;1731-1735.
21. Quinnan G.V., Kirmani N., Rook A.H., Manischewitz J.F., Jackson L., Moreschi G., Santos G.W., Saral R., Burns W.H. Cytotoxic T-cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N. Engl. J. M. 307:1982;7-13.
22. Slavin M., Dobbs S., Crawford S., Bowden R. Interleukin-2, interferon-gamma and natural killer cell activity in bronchoalveolar lavage fluid from marrow transplant recipients with cytomegalovirus pneumonia. Bone Marrow Transplant. 11:1993;113-118.
23. Fitzgerald N.A., Shellam G.R. Host genetic influences on fetal susceptibility to murine cytomegalovirus after maternal or fetal infection. J. Infect. Dis. 163:1991;276-281.
24. Shanley J.D., Biczak L., Forman S.J. Acute murine cytomegalovirus infection induces lethal hepatitis. J. Infect. Dis. 167:1993;264-269.
25. Fitzgerald N.A., Shellam G.R. Host genetic influences on fetal susceptibility to murine cytomegalovirus after maternal or fetal infection. J. Infect. Dis. 163:1991;276-281.
26. Shellam G.R., Allan J.E., Papadimitriou J.M., Bancroft G.J. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. USA. 78:1981;5104-5108.
27. Bancroft G.J., Shellam G.R., Chalmer J.E. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126:1981;988-994.
28. Roder J., Duwe A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature. 278:1979;451-453.
29. Bukowski J.F., Woda B.A., Welsh R.M. Pathogenesis of murine cytomegalovirus infection in natural killer cell- depleted mice. J. Virol. 52:1984;119-128.
30. Welsh R.M., Dundon P.L., Eynon E.E., Brubaker J.O., Koo G.C., O'Donnell C.L. Demonstration of the antiviral role of natural killer cells in vivo with a natural killer cell-specific monoclonal antibody (NK 1.1). Nature Immun. Cell Growth Regul. 9:1990;112-120.
31. Bukowski J.F., Warner J.F., Dennert G., Welsh R.M. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. M. 161:1985;40-52.
32. Tay C.H., Welsh R.M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:1997;267-275.
33. Orange J.S., Biron C.A. An absolute and restricted requirement for IL-12 in natural killer cell IFN-g production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1996;1138-1142.
34. Salazar-Mather T.P., Orange J.S., Biron C.A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J. Exp. M. 187:1998;1-14.
35. Grundy J.E., Mackenzie J.S., Stanley N.F. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect. Immun. 32:1981;277-286.
36. Chalmer J.E., Mackenzie J.S., Stanley N.F. Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J. Gen. Virol. 37:1977;107-114.
37. Price P., Winter J.G., Nikoletti S., Hudson J.B., Shellam G.R. Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection. J. Virol. 61:1987;3602-3606.
38. Wykes M.N., Shellam G.R., McCluskey J., Kast W.M., Dallas P.B., Price P. Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection. J. Virol. 67:1993;4182-4189.
39. Allan J.E., Shellam G.R. Characterization of interferon induction in mice of resistant and susceptible strains during murine cytomegalovirus infection. J. Gen. Virol. 66:(Pt 5):1985;1105-1112.
40. Scalzo A.A., Fitzgerald N.A., Simmons A., La Vista A.B., Shellam G.R. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. M. 171:1990;1469-1483.
41. Price P., Olver S.D., Gibbons A.E., Teo H.K., Shellam G.R. Characterization of thymic involution induced by murine cytomegalovirus infection. Immunol. Cell Biol. 71:(Pt 3):1993;155-165.
42. Forbes C.A., Brown M.G., Cho R., Shellam G.R., Yokoyama W.M., Scalzo A.A. The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell gene complex on mouse chromosome 6. Genomics. 41:1997;406-413.
43. Brown M.G., Scalzo A.A., Matsumoto K., Yokoyama W.M. The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol. Rev. 155:1997;53-65.
44. Brown M.G., Fulmek S., Matsumoto K., Cho R., Lyons P.A., Levy E.R., Scalzo A.A., Yokoyama W.M. A 2-Mb YAC contig and physical map of the natural killer gene complex on mouse chromosome 6. Genomics. 42:1997;16-25.
45. Plougastel B., Dubbelde C., Yokoyama W.M. Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69. Immunogenetics. 53:2001;209-214.
46. Sobanov Y., Bernreiter A., Derdak S., Mechtcheriakova D., Schweighofer B., Duchler M., Kalthoff F., Hofer E. A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex. Eur. J. Immunol. 31:2001;3493-3503.
47. Renedo M., Arce I., Montgomery K., Roda-Navarro P., Lee E., Kucherlapati R., Fernandez-Ruiz E. A sequence-ready physical map of the region containing the human natural killer gene complex on chromosome 12p12.3-p13.2. Genomics. 65:2000;129-136.
48. Depatie C., Chalifour A., Pare C., Lee S.H., Vidal S.M., Lemieux S. Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets. Int. Immunol. 11:1999;1541-1551.
49. Brown M.G., Zhang J., Du Y., Stoll J., Yokoyama W.M., Scalzo A.A. Localization on a physical map of the NKC-linked Cmv1 locus between Ly49b and the Prp gene cluster on mouse chromosome 6. J. Immunol. 163:1999;1991-1999.
50. Brown M.G., Scalzo A.A., Stone L.R., Clark P.Y., Du Y., Palanca B., Yokoyama W.M. Natural killer gene complex (Nkc) allelic variability in inbred mice: evidence for Nkc haplotypes. Immunogenetics. 53:2001;584-591.
51. Lee S.H., Gitas J., Zafer A., Lepage P., Hudson T.J., Belouchi A., Vidal S.M. Haplotype mapping indicates two independent origins for the Cmv1 s susceptibility allele to cytomegalovirus infection and refines its localization within the Ly49 cluster. Immunogenetics. 53:2001;501-505.
52. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., Raulet D.H. Mouse CD94/NKG2 A is a natural killer cell receptor for the non-classical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. M. 188:1998;1841-1848.
53. Trowsdale J., Barten R., Haude A., Stewart C.A., Beck S., Wilson M.J. The genomic context of natural killer receptor extended gene families. Immunol. Rev. 181:2001;20-38.
54. Westgaard I.H., Berg S.F., Orstavik S., Fossum S., Dissen E. Identification of a human member of the Ly-49 multigene family. Eur. J. Immunol. 28:1998;1839-1846.
55. Ikeda H., Lethe B., Lehmann F., van Baren N., Baurain J.F., de Smet C., Chambost H., Vitale M., Moretta A., Boon T., Coulie P.G. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity. 6:1997;199-208.
56. Yen J.H., Moore B.E., Nakajima T., Scholl D., Schaid D.J., Weyand C.M., Goronzy J.J. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J. Exp. M. 193:2001;1159-1167.
57. Scalzo A.A., Brown M.G., Chu D.T., Heusel J.W., Yokoyama W.M., Forbes C.A. Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics. 49:1999;238-241.
58. Depatie C., Muise E., Lepage P., Gros P., Vidal S.M. High-resolution linkage map in the proximity of the host resistance locus Cmv1. Genomics. 39:1997;154-163.
59. Depatie C., Lee S.H., Stafford A., Avner P., Belouchi A., Gros P., Vidal S.M. Sequence-ready BAC contig, physical, and transcriptional map of a 2-Mb region overlapping the mouse chromosome 6 host-resistance locus Cmv1. Genomics. 66:2000;161-174.
60. Lee S.H., Girard S., Macina D., Busa M., Zafer A., Belouchi A., Gros P., Vidal S.M. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nature Genet. 28:2001;42-45.
61. Yokoyama W.M., Jacobs L.B., Kanagawa O., Shevach E.M., Cohen D.I. A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins. J. Immunol. 143:1989;1379-1386.
62. Chan P.Y., Takei F. Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48. J. Immunol. 142:1989;1727-1736.
63. Makrigiannis A.P., Pau A.T., Schwartzberg P.L., McVicar D.W., Beck T.W., erson S.K. A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics. 79:2002;437-444.
64. Ortaldo J.R., Winkler-Pickett R., Mason A.T., Mason L.H. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells. J. Immunol. 160:1998;1158-1165.
65. Anderson S.K., Ortaldo J.R., McVicar D.W. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol. Rev. 181:2001;79-89.
66. Nakamura M.C., Niemi E.C., Fisher M.J., Shultz L.D., Seaman W.E., Ryan J.C. Mouse Ly-49 A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J. Exp. M. 185:1997;673-684.
67. Smith K.M., Wu J., Bakker A.B., Phillips J.H., Lanier L.L. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161:1998;7-10.
68. McVicar D.W., Taylor L.S., Gosselin P., Willette-Brown J., Mikhael A.I., Geahlen R.L., Nakamura M.C., Linnemeyer P., Seaman W.E., Anderson S.K., Ortaldo J.R., Mason L.H. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J. Biol. Chem. 273:1998;32934-32942.
69. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R., Beckman D.L., Blattenberger E.A., Dubbelde C.E., Stone L.R., Scalzo A.A., Yokoyama W.M. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science. 292:2001;934-937.
70. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. M. 194:2001;29-44.
71. Smith H.R., Chuang H.H., Wang L.L., Salcedo M., Heusel J.W., Yokoyama W.M. Nonstochastic coexpression of activation receptors on murine natural killer cells. J. Exp. M. 191:2000;1341-1354.
72. Gosselin P., Mason L.H., Willette-Brown J., Ortaldo J.R., McVicar D.W., Anderson S.K. Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J. Leukoc. Biol. 66:1999;165-171.
73. Sjolin H., Tomasello E., Mousavi-Jazi M., Bartolazzi A., Karre K., Vivier E., Cerboni C. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. M. 195:2002;825-834.
74. Schwartz S., Zhang Z., Frazer K.A., Smit A., Riemer C., Bouck J., Gibbs R., Hardison R., Miller W. PipMaker - a web server for aligning two genomic DNA sequences. Genome Res. 10:2000;577-586.
75. Takei F., McQueen K.L., Maeda M., Wilhelm B.T., Lohwasser S., Lian R.H., Mager D.L., Ly C.D. NKG2: developmentally regulated expression and evolution. Immunol. Rev. 181:2001;90-103.
76. Kataoka N., Diem M.D., Kim V.N., Yong J., Dreyfuss G. Magoh, a human homolog of Drosophila mago nashi protein, is a component of the splicing-dependent exon-exon junction complex. EMBO J. 20:2001;6424-6433.
77. Capowski E.E., Esnault S., Bhattacharya S., Malter J.S. Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J. Immunol. 167:2001;5970-5976.
78. Takei F., Brennan J., Mager D.L. The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol. Rev. 155:1997;67-77.
79. Karre K., Ljunggren H.G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 319:1986;675-678.
80. Farrell H.E., Vally H., Lynch D.M., Fleming P., Shellam G.R., Scalzo A.A., Davis-Poynter N.J. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature. 386:1997;510-514.
81. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 296:2002;1323-1326.
82. Mason L.H., Willette-Brown J., Mason A.T., McVicar D., Ortaldo J.R. Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-g secretion. J. Immunol. 164:2000;603-611.
83. Arnon T.I., Lev M., Katz G., Chernobrov Y., Porgador A., Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31:2001;2680-2689.
84. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 409:2001;1055-1060.
85. Idris A.H., Iizuka K., Smith H.R., Scalzo A.A., Yokoyama W.M. Genetic control of natural killing and in vivo tumor elimination by the Chok locus. J. Exp. M. 188:1998;2243-2256.
86. Beebe A.M., Mauze S., Schork N.J., Coffman R.L. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity. 6:1997;551-557.
87. Melanitou E., Joly F., Lathrop M., Boitard C., Avner P. Evidence for the presence of insulin-dependent diabetes-associated alleles on the distal part of mouse chromosome 6. Genome Res. 8:1998;608-620.
88. Delano M.L., Brownstein D.G. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J. Virol. 69:1995;5875-5877.
89. Dissen E., Ryan J.C., Seaman W.E., Fossum S. An autosomal dominant locus, Nka, mapping to the Ly-49 region of a rat natural killer (NK) gene complex, controls NK cell lysis of allogeneic lymphocytes. J. Exp. M. 183:1996;2197-2207.
90. Jansson A.M., Jacobsson L., Luthman H., Lorentzen J.C. Susceptibility to oil-induced arthritis is linked to Oia2 on chromosome 4 in a DA(DA x PVG.1 AV1) backcross. Transplant. Proc. 31:1999;1597-1599.
91. Idris A.H., Smith H.R., Mason L.H., Ortaldo J.R., Scalzo A.A., Yokoyama W.M. The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc. Natl. Acad. Sci. USA. 96:1999;6330-6335.
92. Brownstein D.G., Bhatt P.N., Gras L., Jacoby R.O. Chromosomal locations and gonadal dependence of genes that mediate resistance to ectromelia (mousepox) virus-induced mortality. J. Virol. 65:1991;1946-1951.
93. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nature Immunol. 1:2000;119-126.
94. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285:1999;730-732.
95. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T-cells by NKG2D, a receptor for stress- inducible MICA. Science. 285:1999;727-729.
96. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 14:2001;123-133.
97. Raulet D.H., Vance R.E., McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19:2001;291-330.
98. Rogner U.C., Boitard C., Morin J., Melanitou E., Avner P. Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains. Genomics. 74:2001;163-171.
99. Paloneva J., Kestila M., Wu J., Salminen A., Bohling T., Ruotsalainen V., Hakola P., Bakker A.B., Phillips J.H., Pekkarinen P., Lanier L.L., Timonen T., Peltonen L. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nature Genet. 25:2000;357-361.